Mepitel ME290500 Soft Silicone Wound Contact Layer with Safetac Technology, 5 cm Width, 7 cm Length (Pack of 5)

Product Information

If the product is not used properly on burns treated with meshed grafts or after facial resurfacing imprints can occur. White R (2008) A multinational survey of the assessment of pain when removing dressings. Wounds UK 4(1): 14-22 Safetac also protects new tissue and intact skin – so wounds remain undisturbed to support faster natural healing . And it seals the wound margins to protect skin from damaging leaks and maceration . Adamietz IA, Mose S, Haberl A, et al (1994) Effect of Self-Adhesive, Silicone-Coated Polyamide Net Dressing on Irradiated Human Skin. Radiat Oncol Investig 2(6): 277-282 Mepitel One used after facial resurfacing: avoid placing pressure upon the dressing lift and reposition the dressing at least every second day.

The literature search identified a number of articles, presenting data generated from randomized controlled trials, non-randomized controlled trials and case study evaluations of Mepitel on a wide range of wound types and skin injuries. Edwards J, Mason S (2013) Hand burn management: minimizing pain and trauma at dressing change. Br J Nurs 2(20): S46-S50 If used on epidermolysis bullosa patients, employ extra surveillance at dressing changes. Adhesion level of Mepitel® One is somewhat higher than that of Mepitel®.Mepitel is clinically provento enable faster healing with less pain and cost, compared to silver sulfadiazine The wound should be inspected for signs of infection according to clinical practice. Consult a health care professional for the appropriate medical treatment. When Mepitel is used for the fixation of skin grafts and protection of blisters, the dressing should not be changed before the fifth day post application.

The wound should be inspected for signs of infection according to clinical practice. Consult a healthcare professional for the appropriate medical treatment. In an open, two-arm, multi-centre, parallel-group randomised controlled trial of outpatients with moderately exudating, uncomplicated acute wounds, David et al (2017) compared Mepitel ® One with a soft silicone adhesive layer with a lipido-colloid adhesive layer. In 123 patients, the randomised clinical trial found Mepitel ® One was significantly less painful to remove compared to a lipido-colloid adhesive layer. A comparison on healing by day 21 was made. At this time, significantly more patients treated with Mepitel One had healed compared to those treated with a lipido-colloid adhesive layer. When used after facial resurfacing, avoid placing pressure upon the dressing. Lift and reposition the dressing at least every second day. When used on bleeding wounds or wounds with high viscosity exudate, Mepitel One should be covered with a moist absorbent dressing pad. When used on burns treated with meshed grafts or after facial resurfacing, imprints can occur if the product is not used properly.Soft, thin, breathable and waterproof film is highly conformable and contributes to optimum patient protection & comfort Safetac also protects new tissue and intact skin, so wounds remain undisturbed, to support faster healing. Mepitel seals the wound margins to protect skin from damaging leaks and maceration. When used on bleeding wounds or wounds with high-viscosity exudate, Mepitel® One should be covered with a moist, absorbent dressing pad. The design includes a Safetac ® interface which seals the wound edges, preventing the exudate to leak onto the surroundingskin, thus minimising the risk for maceration . Safetac interface also minimises damaging the wound or surrounding skin orexposing the patient to additional pain at dressing changes . Mepitel used after facial resurfacing: avoid placing pressure upon the dressing lift and reposition the dressing at least every second day.

Collin (2009) describes the use of Mepitel ® One following hand surgery in a non-comparative, ten patient case series. The author found dressing conformability was rated by the investigator as ‘good’ to ‘very good’; handling at application and ease of removal were generally rated as ‘easy’ to ‘very easy’. The patients also rated dressing conformability and comfort as ‘good’ to ‘very good’. No pain was associated with the removal of the Mepitel One dressings. There were no reports of leakage or dressing displacement. All wounds responded well and were associated with, at worst, minimal bleeding or exudation (as would be expected of this type of wound). No odour or signs of infection/ inflammation were reported. The condition of the peri-wound skin was generally healthy although mild maceration developed around one of the wounds. Since its launch in 2009, a number of studies have highlighted the benefits of using Mepitel ® One. The results of the clinical evaluations demonstrate that Mepitel is associated with atraumatic and virtually pain-free dressing changes. The dressing with Safetac can be used cost-effectively in the treatment of a wide range of wound types and skin injuries.If Mepitel One is used on Epidermolysis Bullosa patients, employ extra surveillance at dressing changes. Adhesion level of Mepitel One is somewhat higher than of Mepitel. When used on bleeding wounds or wounds with high viscosity exudate, Mepitel should be covered with a moist absorbent dressing pad. Waring M, Bielfeldt S, Mätzold K, Wilhelm KP, Butcher M (2011) An evaluation of the skin stripping of wound dressing adhesives. J Wound Care 20(9): 412-422 The nature of the bond that forms between Mepitel and the skin surface is such that the dressing can be removed with minimum pain and without damaging delicate new tissue.